Harnessing Immunity to Treat Advanced Thyroid Cancer
The incidence of thyroid cancer (TC) has increased over the past 30 years. Although differentiated thyroid cancer (DTC) has a good prognosis in most patients undergoing total thyroidectomy followed by radioiodine therapy (RAI), 5–10% of patients develop metastasis. Anaplastic thyroid cancer (ATC) ha...
Main Authors: | Hiroki Komatsuda, Michihisa Kono, Risa Wakisaka, Ryosuke Sato, Takahiro Inoue, Takumi Kumai, Miki Takahara |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-12-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/12/1/45 |
Similar Items
-
Antitumor Peptide-Based Vaccine in the Limelight
by: Takumi Kumai, et al.
Published: (2022-01-01) -
Exploring Immunological Effects and Novel Immune Adjuvants in Immunotherapy for Salivary Gland Cancers
by: Ryosuke Sato, et al.
Published: (2024-03-01) -
Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma
by: Michihisa Kono, et al.
Published: (2022-12-01) -
Editorial: Targeted therapy in advanced thyroid cancer
by: Laura Boucai
Published: (2022-09-01) -
Dawn of Advanced Thyroid Cancer Therapy: Targeted Therapy and Immunotherapy
by: LIU Shanting, et al.
Published: (2023-01-01)